259 related articles for article (PubMed ID: 22159584)
1. CHFR: a key checkpoint component implicated in a wide range of cancers.
Sanbhnani S; Yeong FM
Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
Privette LM; González ME; Ding L; Kleer CG; Petty EM
Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
[TBL] [Abstract][Full Text] [Related]
3. CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer.
Gao Y; Lou G; Zhang GM; Sun XW; Ma YY; Yang YM; Liu G
Int J Biol Markers; 2009; 24(2):83-9. PubMed ID: 19634111
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.
Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T
Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
6. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
Jiang G; Fang H; Shang X; Chen X; Cao F
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
[TBL] [Abstract][Full Text] [Related]
7. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
Fukuda T; Kondo Y; Nakagama H
PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
Soutto M; Peng D; Razvi M; Ruemmele P; Hartmann A; Roessner A; Schneider-Stock R; El-Rifai W
Cancer; 2010 Sep; 116(17):4033-42. PubMed ID: 20564104
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
Oki E; Zhao Y; Yoshida R; Masuda T; Ando K; Sugiyama M; Tokunaga E; Morita M; Kakeji Y; Maehara Y
World J Gastroenterol; 2009 May; 15(20):2520-5. PubMed ID: 19469003
[TBL] [Abstract][Full Text] [Related]
11. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
[TBL] [Abstract][Full Text] [Related]
12. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.
Gao YJ; Xin Y; Zhang JJ; Zhou J
World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281
[TBL] [Abstract][Full Text] [Related]
13. CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel.
Wang X; Yang Y; Xu C; Xiao L; Shen H; Zhang X; Li T; Li X
Int J Gynecol Cancer; 2011 Aug; 21(6):996-1003. PubMed ID: 21792009
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR).
Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R
J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844
[TBL] [Abstract][Full Text] [Related]
15. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.
Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM
Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
18. Chfr is required for tumor suppression and Aurora A regulation.
Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J
Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587
[TBL] [Abstract][Full Text] [Related]
19. Methylation of gene CHFR promoter in acute leukemia cells.
Gong H; Liu W; Zhou J; Xu H
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):240-2. PubMed ID: 16201259
[TBL] [Abstract][Full Text] [Related]
20. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
